Robin Luper, CEO of JS Consulting, will be attending the EuroPCR Congress in Paris this week. This annual scientific gathering of leading cardiologists from around the world showcases the latest interventional device technologies and discusses the latest research and late breaking news on clinical trial results.
Robin will hold meetings with many key opinion leaders and device companies, and will also be supporting the management of RenalGuard, one of our premier clients who are exhibiting a device for managing contrast induced acute kidney injury.
If you are at EuroPCR or in Paris this week and would like to meet with Robin, please contact us to arrange a convenient time.
